Sylvia Adams
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 17, 2023
A Case of Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Metaplastic Breast Cancer.Anita Gul, J Jaime Alberty-Oller, Jagbir Sandhu
|Apr 26, 2023
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis.Sherene Loi, Roberto Salgado, Peter Schmid
|Jun 07, 2021
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.Hope S Rugo, Sherene Loi, Sylvia Adams
|Feb 01, 2021
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.Leisha A Emens, Luciana Molinero, Sherene Loi
|Feb 10, 2018
Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here.Maryann J Kwa, Sylvia Adams
|Nov 11, 2017
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.Maryann Kwa, Xiaochun Li, Yelena Novik
Pageof 1
Frequent Collaborators
3 joint publications
Sherene Loi
3 joint publications
Hiroji Iwata
3 joint publications
Eric P Winer
2 joint publications
Hope S Rugo
1 joint publications
Dieter Peeters
1 joint publications
Leisha A Emens
1 joint publications
Roberto Salgado
1 joint publications
Peter Schmid
1 joint publications
Javier Cortes
1 joint publications
David W Cescon
